AIM ImmunoTech
AIM
#9888
Rank
โ‚น1.05 B
Marketcap
โ‚น16.61
Share price
3.94%
Change (1 day)
-60.06%
Change (1 year)

P/E ratio for AIM ImmunoTech (AIM)

P/E ratio as of December 2024 (TTM): -0.4875

According to AIM ImmunoTech 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.4875. At the end of 2022 the company had a P/E ratio of -0.7750.

P/E ratio history for AIM ImmunoTech from 2001 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-0.7750-66.3%
2021-2.30-35.75%
2020-3.583355.59%
2019-0.1036-87.38%
2018-0.8207-32%
2017-1.21-42.28%
2016-2.0976.42%
2015-1.19-56.15%
2014-2.700.1%
2013-2.7029.6%
2012-2.08-16.67%
2011-2.50-54.08%
2010-5.44-22.22%
2009-7.00211.11%
2008-2.25-28.95%
2007-3.17-55.38%
2006-7.10-18.24%
2005-8.68114.72%
2004-4.04-23.08%
2003-5.26-43.25%
2002-9.26-40.32%
2001-15.5

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
-0.9953 104.16%๐Ÿ‡บ๐Ÿ‡ธ USA
-5.59 1,047.20%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.